Lee Ainslie Amgen Inc Transaction History

Maverick Capital LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $411,499 - $510,887	1,882 New	1,882 $505,000
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $354,490 - $415,329	-1,670 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $364,618 - $404,517	1,561 Added 1432.11%	1,670 $407,000
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $24,188 - $28,187	109 New	109 $27,000
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $919,939 - $1.18 Million	-4,862 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $846,522 - $1.01 Million	4,862 New	4,862 $941,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.